A randomized, placebo-controlled, double-blinded, crossover trial of pioglitazone for severe asthma.

ABSTRACT:

SUBMITTER: Kaler M 

PROVIDER: S-EPMC5723231 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature